Biospeciman

Automated sample storage and handling systems are manufactured.

About Biospeciman

Biospeciman is a Healthcare company, and was acquired by Brooks Automation in April 2018. Automated sample storage and handling systems are manufactured.

Company details

Automated cryogenic and cold storage systems, along with sample management software, are manufactured in the biotechnology sector. Consumables and instruments for sample handling are supplied, while services such as storage, relocation, and transportation are provided. Laboratory information management systems for biobanking and cell line management are offered. These products and services support operations in research, clinical trials, and biopharmaceutical manufacturing.

Key Metrics

Investors in Biospeciman

Biospeciman has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Brooks Automation.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Vacuum robots for semiconductor wafer handling are developed.
1978brooks.comChelmsford, United States
Premium access

Investor details for Biospeciman

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Biospeciman

Automated cryogenic and cold storage systems, along with sample management software, are manufactured in the biotechnology sector. Consumables and instruments for sample handling are supplied, while services such as storage, relocation, and transportation are provided. Laboratory information management systems for biobanking and cell line management are offered. These products and services support operations in research, clinical trials, and biopharmaceutical manufacturing.

Biospeciman has 1 investor. Key investors include Brooks Automation.

Yes. Biospeciman was acquired by Brooks Automation in April 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available